SBI Nifty100 Low Volatility 30 Index Fund
The scheme seeks to provide returns that correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Growthvine rating: 1/5 — ranked #36 of 42 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹10.21 (as of 2026-11-13) |
|---|
| AUM | ₹52 Cr |
|---|
| Expense ratio | 0.67% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Viral Chhadva |
|---|
| Exit load | 0.25% for redemption within 15 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −14.37% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 87.6% of NIFTY 100's upside and 90.9% of its downside.
Market cap allocation
| Large cap | 96.5% |
|---|
| Mid cap | 3.5% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 19.6% |
|---|
| Top 10 holdings | 37.3% |
|---|
| Total holdings | 30 |
|---|
| Index overlap | 43.6% |
|---|
| Active share | 56.4% |
|---|
Top holdings
- Bharti Airtel Ltd. — 4.1%
- ICICI Bank Ltd. — 4.0%
- Kotak Mahindra Bank Ltd. — 4.0%
- Apollo Hospitals Enterprises Ltd. — 3.9%
- Sun Pharmaceutical Industries Ltd. — 3.7%
- NTPC Limited — 3.7%
- Dr. Reddys Laboratories Ltd. — 3.5%
- Britannia Industries Ltd. — 3.5%
- SBI Life Insurance Company Limited — 3.5%
- ITC Ltd — 3.5%
Top sectors
- Banking & Financial — 14.3%
- Pharma & Biotech — 13.8%
- Energy — 10.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −4.1% | Q4 (Bottom) | #39 of 39 |